NCT01037998
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
- Locations
-
- Taipei VGH Taipei, Taiwan
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
445 public trials
103 recruiting studies
Adenocarcinoma trial results
NCT00955019
- Conditions
- Adenocarcinoma, Barrett Esophagus, Carcinoma, +10 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00495924
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +17 more
- Locations
-
- Department of Abdominal Surgery, Catholic University Leuven Leuven, Vlaams-Brabant, Belgium
NCT00259987
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +2 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Ann Arbor, Michigan, United States
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Amsterdam, Netherlands
NCT00102700
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
- Locations
-
- University of South Alabama Mobile, Alabama, United States
- Moores UCSD Cancer Center La Jolla, California, United States
- Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
- Scripps Cancer Center San Diego, California, United States
NCT00377936
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +15 more
- Locations
-
- Prague, Czechia
- Budapest, Hungary
- Kiev, Ukraine
Completed
Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer
NCT00129844
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
- Locations
-
- Fountain Valley, California, United States
- Los Angeles, California, United States
- Palm Springs, California, United States
- Columbia, Missouri, United States
NCT00001569
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Carcinoma, +9 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Completed
A Long Term Safety Study With Atrasentan
NCT00127478
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
- Locations
-
- Prostate Oncology Specialists Marina del Rey, California, United States
- Western Clinical Research, Inc. Torrance, California, United States
- South Florida Medical Research Aventura, Florida, United States
- Beth Isreal Medical Center, Phillips Ambulatory Care Ceneter New York, United States
NCT00191503
- Conditions
- Adenocarcinoma, Carcinoma, Neoplasms, +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Calgary, Alberta, Canada
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Edmonton, Alberta, Canada